
TATVATatva Chintan Pharma Chem Ltd
Tatva Chintan Pharma Chem Q2 FY27 Results: Consolidated Net Profit ₹21.45 Crore on Total Income of ₹219 Crore
Tatva Chintan Pharma Chem reported consolidated total income of ₹219.07 crore and net profit of ₹21.45 crore for the quarter ended 30 Sep 2026. Standalone total income was ₹210.19 crore and net profit was ₹15.39 crore.
- Earnings
- Specialty Chemicals